The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis

In conclusion, we have designed a dual-acting peptide capable of brain penetration and TNBC cell elimination, thus expanding the drug arsenal to fight this BC subtype and its BM.PMID:38613996 | DOI:10.1016/j.biopha.2024.116573

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - April 13, 2024 Category: Drugs & Pharmacology Authors: Marco Cavaco Clara P érez-Peinado Javier Valle Ruben D M Silva Lurdes Gano Jo ão D G Correia David Andreu Miguel A R B Castanho Vera Neves Source Type: research